These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 16877370

  • 1. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
    Bedaiwy MA, Forman R, Mousa NA, Al Inany HG, Casper RF.
    Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
    [Abstract] [Full Text] [Related]

  • 2. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
    Mitwally MF, Casper RF.
    J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
    [Abstract] [Full Text] [Related]

  • 3. Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination.
    Bedaiwy MA, Shokry M, Mousa N, Claessens A, Esfandiari N, Gotleib L, Casper R.
    Fertil Steril; 2009 Jun; 91(6):2501-7. PubMed ID: 18501899
    [Abstract] [Full Text] [Related]

  • 4. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K, Chaudhury S, Khastgir G, Purakaystha S.
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN.
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.
    Gerli S, Casini ML, Unfer V, Costabile L, Bini V, Di Renzo GC.
    Fertil Steril; 2004 Sep; 82(3):573-8. PubMed ID: 15374698
    [Abstract] [Full Text] [Related]

  • 10. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L, Noriega-Hoces L, Delgado A, Rubio J, Gonzales-Castañeda C, Gonzales GF.
    Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
    [Abstract] [Full Text] [Related]

  • 11. Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical effectiveness.
    Ryan GL, Moss V, Davis WA, Sparks AE, Dokras A, Van Voorhis BJ.
    J Reprod Med; 2005 Dec; 50(12):943-50. PubMed ID: 16444896
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome.
    Zeinalzadeh M, Basirat Z, Esmailpour M.
    J Reprod Med; 2010 Dec; 55(1-2):36-40. PubMed ID: 20337206
    [Abstract] [Full Text] [Related]

  • 13. Follicular phase dynamics with combined aromatase inhibitor and follicle stimulating hormone treatment.
    Bedaiwy MA, Mousa NA, Esfandiari N, Forman R, Casper RF.
    J Clin Endocrinol Metab; 2007 Mar; 92(3):825-33. PubMed ID: 17192292
    [Abstract] [Full Text] [Related]

  • 14. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
    Dankert T, Kremer JA, Cohlen BJ, Hamilton CJ, Pasker-de Jong PC, Straatman H, van Dop PA.
    Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
    [Abstract] [Full Text] [Related]

  • 15. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study.
    Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH.
    Fertil Steril; 2006 Jun; 85(6):1774-7. PubMed ID: 16677640
    [Abstract] [Full Text] [Related]

  • 16. Letrozole vs. clomiphene citrate in patients with ovulatory infertility.
    Bayar U, Tanriverdi HA, Barut A, Ayoğlu F, Ozcan O, Kaya E.
    Fertil Steril; 2006 Apr; 85(4):1045-8. PubMed ID: 16580393
    [Abstract] [Full Text] [Related]

  • 17. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
    Erdem A, Erdem M, Atmaca S, Guler I.
    Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of superovulation with two different doses of letrozole.
    Al-Fadhli R, Sylvestre C, Buckett W, Tan SL, Tulandi T.
    Fertil Steril; 2006 Jan; 85(1):161-4. PubMed ID: 16412748
    [Abstract] [Full Text] [Related]

  • 19. A comparison of letrozole to gonadotropins for ovulation induction, in subjects who failed to conceive with clomiphene citrate.
    Quintero RB, Urban R, Lathi RB, Westphal LM, Dahan MH.
    Fertil Steril; 2007 Oct; 88(4):879-85. PubMed ID: 17920403
    [Abstract] [Full Text] [Related]

  • 20. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
    Kabli N, Sylvestre C, Tulandi T, Buckett W.
    Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.